Yes. These include:
- The ProtectT Trial – evaluating the effectiveness of treatment for clinically localised prostate cancer. This is a large scale randomised controlled trial of treatments for localised prostate cancer detected by PSA-test screening.
- The Department of Health and other National Cancer Research Institute (NCRI) members fund the NCRI Prostate Cancer Collaboratives.
- A highly innovative study to create and test a new non-invasive treatment for prostate cancer. The technique uses magnetic resonance imaging (MRI) to locate the cancer and High Intensity Focused Ultrasound (HIFU) to destroy it inside the body.
- MRI for radiotherapy treatment planning – a study to improve radiotherapy treatment for prostate cancer by using magnetic resonance imaging (MRI).